NEW ENTERPRISE ASSOCIATES 15, L.P. / MILLENDO THERAPEUTICS, INC. -- SCHEDULE 13D

Company

Tempest Therapeutics, Inc.

Filed

April 13, 2021

Accession Number

0001072613-21-000364